Posted by
on Jun 30th, 2011 and filed under Roche Loss on Avastin Appeal Is Third in a Row at FDA Panel – San Francisco Chronicle
 Fox News |
Roche Loss on Avastin Appeal Is Third in a Row at FDA Panel
San Francisco Chronicle June 30 (Bloomberg) — Roche Holding AG's failure to persuade a US panel to back Avastin in breast cancer is the third such loss for the Swiss drugmaker as it looks for new ways to expand sales of the world's top-selling cancer medicine. … Medicare will keep covering Roche's Avastin FDA Panel: Revoke Drug's Breast Cancer Approval Medicare Will Pay for Avastin in Treating Breast Cancer |
